Gelonghui May 24| Biotech stocks on the Hong Kong stock market fell across the board today. Affected by rumors that "clinical data fell short of expectations"13poker, Kangfang Biotech plunged more than 34%13poker, leading to the collapse of the entire biotechnology sector, Lepu Biotech fell more than 11%, Kelun Botai Biotech, Baiji Shenzhou, and Kingsrisheng fell more than 8%, Rongchang Biotech and Zaiding Pharmaceutical fell more than 7%, Keji Pharmaceutical, Kangnoya fell more than 6%, and Laikai Pharmaceutical fell more than 5%.
